Monday, September 29, 2025

Anywhere by Linus Health™ Expands Early Cognitive Access

Related stories

Aisles Launches DREAM: AI-Driven Virtual Reality Evolution

Aisles has unveiled DREAM (Dynamic Reality Experience and Memory),...

TechSee Unveils Visual Remote Assistance with AI (VRAi) on Salesforce

TechSee, a global leader in visual customer assistance, announced...

Rendever and Lenovo Collaborate to Bring Virtual Reality Experiences to Carolina Caring Seniors

Rendever, the Boston-based company pioneering the future of aging...

Ansys 2024 R1 Reimagines the User Experience while Expanding Multiphysics Superiority Boosted by AI

The latest release from Ansys, 2024 R1, introduces an elevated user...

eXeX and Neurosurgeon Dr. Robert Masson Achieve World First Using Apple Vision Pro

eXeX™, a leader in artificial intelligence and mixed reality...
spot_imgspot_img

Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment platform to payers, pharma, wellness partners and consumers unlocking scalable brain health for all

Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, announced the expanded launch of Anywhere powered by Linus Health™ (Anywhere). This clinically validated cognitive assessment platform harnesses artificial intelligence to deliver accessible, scalable brain health solutions both in-clinic and remotelyto a broad new audience, including payers, pharmaceutical companies, wellness providers, and consumers.

Linus Health is now making its remote, AI-powered cognitive assessments available to a wider set of partners and use cases both inside and outside the traditional healthcare system.

Also Read: Dante Omics AI Brings Genomics to the AI Era With GPUs

“Early detection of cognitive impairment is critical and it shouldn’t be limited to a clinic setting,” said David Bates, PhD, CEO and co-founder of Linus Health. “With Anywhere, we’re making clinical-grade brain health tools accessible at scale whether you’re a payer building a preventive care model, a wellness company promoting cognitive fitness, or an individual taking charge of your own brain health.”

A Scalable Platform for a Growing Brain Health Crisis

As rates of Alzheimer’s disease, mild cognitive impairment and dementia continue to rise globally, the need for accessible, scalable cognitive screening has never been more urgent. Anywhere powered by Linus Health allows individuals to take brief, validated cognitive assessments and answer questionnaires remotely from a browser-based platform on their own time, on their own device, and in their own environment. The various assessments use digital technology and AI to detect subtle cognitive changes often missed by traditional tools.

Key benefits include:

  • For payers: Enables population-level brain health initiatives and supports value-based care strategies
  • For pharma: Facilitates efficient screening and stratification in decentralized clinical trials and real-world evidence generation
  • For wellness providers: Offers a differentiating service to track and support cognitive performance
  • For consumers: Empowers individuals to take proactive steps in monitoring and preserving brain health

Built for Integration and Scale

At the heart of Anywhere is a powerful API infrastructure, allowing seamless integration with third-party platforms from payer portals and digital therapeutics to employer wellness apps and remote clinical trial platforms.

“We’ve built our platform to be embedded anywhere literally,” said John Showalter, MD, MSIS, chief operating officer (COO) at Linus Health. “Our API makes it simple for organizations to bring clinical-grade cognitive insights into their own digital ecosystems and workflows.”

Community Proven. Market Ready.

The recent success of Linus Health’s community cognitive screening pilots demonstrated not only the usability of the Anywhere platform but also the appetite for proactive brain health tools across diverse populations. The expansion to Anywhere marks the next phase in the company’s mission to democratize access to early detection and empower action before cognitive decline becomes irreversible.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img